Pub. Date : 2022 Apr
PMID : 34196110
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | PURPOSE: To evaluate the prognosis of estrogen receptor-positive breast cancer patients with CYP2D6*10 mutant genotypes under tamoxifen or toremifen therapy. | Tamoxifen | estrogen receptor 1 | Homo sapiens |
2 | RESULTS: In total, 293 estrogen receptor-positive breast cancer patients treated with tamoxifen or toremifene between 2008 and 2017 were studied. | Tamoxifen | estrogen receptor 1 | Homo sapiens |
3 | Estrogen receptor-positive breast cancer patients with a CYP2D6*10 mutation genotype have a better prognosis with toremifen than tamoxifen. | Tamoxifen | estrogen receptor 1 | Homo sapiens |